Literature DB >> 10811908

Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.

K X Huang1, H K Paudel.   

Abstract

Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase. Nonphosphorylated I-1 is inactive, whereas phosphorylated I-1 is a potent PP1 inhibitor. I-1 is phosphorylated in vivo on Thr(35) and Ser(67). Thr(35) is phosphorylated by cAMP-dependent protein kinase (A kinase), and Thr(35)-phosphorylated I-1 inhibits PP1. Until now the kinase that phosphorylates Ser(67) had not been identified and the physiological role of Ser(67) phosphorylation was unknown. In this study we detected a high level of kinase activity in brain extract when a glutathione S-transferase (GST) fusion I-1 mutant containing an Ala substituted for Thr(35) [GST-I-1(T35A)] was used as the substrate. GST-I-1(T35A) kinase and neuronal cdc2-like protein kinase (NCLK) in the brain extract could not be separated from each other by a series of sequential chromatographies. GST-I-1(T35A) kinase immunoprecipitated with anti-NCLK antibody from kinase-active column fractions. Purified NCLK-phosphorylated GST-I-1(T35A) and I-1 (0.7 mole of phosphate per mole of I-1). HPLC phosphopeptide mapping, amino acid sequencing, and site-directed mutagenesis determined that NCLK phosphorylates Ser(67) of I-1. NCLK-phosphorylated I-1 and I-1(T35A) inhibited PP1 with IC(50) values approximately 9.5 and 13. 8 nM, respectively. When compared, A kinase-phosphorylated I-1 was only approximately 1.2 times more inhibitory than NCLK-phosphorylated I-1. Our data indicate that NCLK is a potential in vivo I-1 kinase and that Thr(35) and Ser(67) phosphorylation independently activate I-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811908      PMCID: PMC18518          DOI: 10.1073/pnas.100460897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Evidence for presence and hormonal regulation of protein phosphatase inhibitor-1 in ventricular cardiomyocyte.

Authors:  R C Gupta; J Neumann; A M Watanabe; M Lesch; H N Sabbah
Journal:  Am J Physiol       Date:  1996-04

2.  Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1.

Authors:  J Goldberg; H B Huang; Y G Kwon; P Greengard; A C Nairn; J Kuriyan
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

Review 3.  Protein serine/threonine phosphatases--new avenues for cell regulation.

Authors:  S Shenolikar
Journal:  Annu Rev Cell Biol       Date:  1994

4.  A molecular mechanism for the effect of lithium on development.

Authors:  P S Klein; D A Melton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

Authors:  H K Paudel; J Lew; Z Ali; J H Wang
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

6.  Inhibition of cyclin-dependent kinases by purine analogues.

Authors:  J Veselý; L Havlicek; M Strnad; J J Blow; A Donella-Deana; L Pinna; D S Letham; J Kato; L Detivaud; S Leclerc
Journal:  Eur J Biochem       Date:  1994-09-01

7.  Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2.

Authors:  J Lew; R J Winkfein; H K Paudel; J H Wang
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

8.  Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression.

Authors:  R M Mulkey; S Endo; S Shenolikar; R C Malenka
Journal:  Nature       Date:  1994-06-09       Impact factor: 49.962

9.  Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.

Authors:  S Endo; X Zhou; J Connor; B Wang; S Shenolikar
Journal:  Biochemistry       Date:  1996-04-23       Impact factor: 3.162

10.  A family of human cdc2-related protein kinases.

Authors:  M Meyerson; G H Enders; C L Wu; L K Su; C Gorka; C Nelson; E Harlow; L H Tsai
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  13 in total

1.  A versatile mass spectrometry-based method to both identify kinase client-relationships and characterize signaling network topology.

Authors:  Nagib Ahsan; Yadong Huang; Alejandro Tovar-Mendez; Kirby N Swatek; Jingfen Zhang; Ján A Miernyk; Dong Xu; Jay J Thelen
Journal:  J Proteome Res       Date:  2013-01-15       Impact factor: 4.466

2.  Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1.

Authors:  J H Connor; D C Weiser; S Li; J M Hallenbeck; S Shenolikar
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  Cyclin-Dependent kinase 5 targeting prevents β-Amyloid aggregation involving glycogen synthase kinase 3β and phosphatases.

Authors:  John Fredy Castro-Alvarez; Alejandro Uribe-Arias; Gloria Patricia Cardona-Gómez
Journal:  J Neurosci Res       Date:  2015-02-24       Impact factor: 4.164

4.  Neuronal cyclin-dependent kinase 5 activity is critical for survival.

Authors:  T Tanaka; T Ohshima; P Rajan; N D Amin; A Cho; T Sreenath; H C Pant; R O Brady; A B Kulkarni
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

5.  Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases.

Authors:  Annelies W Mesman; Esther M Zijlstra-Willems; Tanja M Kaptein; Rik L de Swart; Meredith E Davis; Martin Ludlow; W Paul Duprex; Michaela U Gack; Sonja I Gringhuis; Teunis B H Geijtenbeek
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

Review 6.  Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology.

Authors:  Persoulla Nicolaou; Roger J Hajjar; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2009-05-27       Impact factor: 5.000

7.  Neurofilament tail phosphorylation: identity of the RT-97 phosphoepitope and regulation in neurons by cross-talk among proline-directed kinases.

Authors:  Ju-Hyun Lee; Tej K Pareek; Howard Jaffee; Barry Boland; K Yaragudri Vinod; Niranjana Amin; Ashok B Kulkarni; Harish C Pant; Ralph A Nixon
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

Review 8.  Regulation of Cardiac PKA Signaling by cAMP and Oxidants.

Authors:  Friederike Cuello; Friedrich W Herberg; Konstantina Stathopoulou; Philipp Henning; Simon Diering
Journal:  Antioxidants (Basel)       Date:  2021-04-24

9.  Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology.

Authors:  Persoulla Nicolaou; Evangelia G Kranias
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

Review 10.  A review of the underlying genetics and emerging therapies for canine cardiomyopathies.

Authors:  L Shen; A H Estrada; K M Meurs; M Sleeper; C Vulpe; C J Martyniuk; C A Pacak
Journal:  J Vet Cardiol       Date:  2021-05-21       Impact factor: 1.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.